But, itâEUR(TM)s also the story of the struggles of Medtronic, Cyberonics, ANS, and the other device companies that must convince the medical community to see neurostimulation as a viable alternative to drug therapy.The article appears in todayâEUR(TM)s Boston Globe and Philadelphia Inquirer. ItâEUR(TM)s a breath of fresh air, and it reminds us just how hard the industry is working to improve peopleâEUR(TM)s lives.
MDDI Online is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.